What this query usually means
This search is usually high intent because the person is already on treatment and is deciding what comes next.
Finasteride changes DHT signaling rather than simply relaxing the bladder outlet. That difference explains why many finasteride questions are about months rather than days, prostate size rather than immediate flow, and PSA interpretation rather than only symptom scores.
Why treatment can seem ineffective
Finasteride is most relevant when prostate enlargement and progression risk are part of the problem. Urgency, nocturia or frequency may also reflect bladder dysfunction, sleep disorders, fluid timing, diabetes, infection or other causes that finasteride does not directly fix.
Clinical interpretation should stay anchored to the reason finasteride was prescribed. A symptom, laboratory change or lack of benefit can mean different things depending on prostate size, treatment duration, adherence, other medicines and the original treatment goal.
How to turn this into a useful treatment discussion
Review whether the problem is insufficient time, poor adherence, a symptom not primarily driven by prostate enlargement, a need for combination therapy, or a reason to discuss a procedure.
Bring the prescriber a concise timeline: when treatment started, which symptoms changed, which did not, any sexual or breast-related symptoms, recent PSA values, and whether doses were missed. That is much more actionable than a vague statement that the medicine “isn’t working.”
What the major sources support
NIDDK lists finasteride and dutasteride among 5-alpha-reductase inhibitors used for BPH because they can stop prostate growth or shrink the prostate. U.S. prescribing information documents effects on PSA and sexual adverse reactions. The AUA guideline places 5-alpha-reductase inhibitors within a broader decision framework that considers prostate enlargement, symptom burden and progression risk.
Questions to discuss with your clinician
- What was the main reason finasteride was chosen for me: prostate size, progression risk, urinary symptoms, or a combination?
- How long should we give this treatment before deciding whether the benefit is adequate?
- How should my PSA be interpreted while I am taking finasteride, and what change would trigger further evaluation?
- If side effects or persistent symptoms are a problem, which alternatives preserve the benefits I still need?
Frequently asked questions
How long should I wait before deciding finasteride failed?
That depends on the treatment goal and clinical context. Finasteride is generally assessed over months, not days, because its prostate-volume effects are gradual.
Can a clinician add an alpha blocker if symptoms persist?
Combination therapy is used in selected men because alpha blockers and 5-alpha-reductase inhibitors target different parts of BPH treatment.
Could nocturia persist even if finasteride is helping the prostate?
Yes. Nighttime urination can have non-prostate causes, so persistent nocturia does not prove finasteride has failed biologically.
When should a procedure enter the conversation?
Procedures may be discussed when medicines do not provide enough relief, side effects are unacceptable, complications develop or the patient prefers a procedural strategy.
Should I stop finasteride if I think I have a side effect?
Do not stop a prescription medication solely on the basis of an online article. Contact the prescriber to review severity, timing, other possible causes and reasonable alternatives.
Can finasteride and tamsulosin be used together?
They can be prescribed together in selected men because they work differently. Whether combination therapy makes sense depends on prostate size, symptom burden, progression risk and tolerance.
Does finasteride shrink the prostate?
Finasteride is used in BPH partly because 5-alpha-reductase inhibition can reduce prostate growth and shrink enlarged prostate tissue over time.
Is finasteride appropriate for every man with BPH symptoms?
No. Treatment choice depends on symptom burden, prostate size, PSA, other conditions, current medicines, side-effect priorities and patient preferences.
Does finasteride treat prostate cancer?
Finasteride is not a treatment for prostate cancer. Because it changes PSA levels, prostate-cancer screening and PSA trends require appropriate clinical interpretation.
What should I tell my clinician before a PSA test?
Tell the clinician that you take finasteride, how long you have taken it and whether you have missed doses or recently stopped, because this can affect interpretation.
Can online symptom scores tell me which prescription drug to use?
No. They can help organize questions, but prescription selection requires clinical evaluation and should account for examination findings, medication history and other health factors.
When do urinary symptoms need urgent medical care?
Seek prompt care for inability to urinate, severe lower abdominal pain, fever with urinary symptoms, visible blood in urine, fainting or other severe symptoms.
Sources
Realvigor prioritizes U.S. prescribing information, public-health references and clinical guidelines. Source links open in a new tab.
Related finasteride decisions
Finasteride guide
Core BPH medication hub for mechanism, PSA effects, side effects and related decisions.
Tamsulosin vs Finasteride
Compare a fast symptom-relief alpha blocker with a prostate-shrinking 5-alpha-reductase inhibitor.
Finasteride sexual side effects
Review erectile, libido and ejaculation concerns with source-based context.
PSA while taking finasteride
Understand why PSA interpretation changes during finasteride treatment.
Finasteride not working
Research timeline, prostate size, symptom pattern and next questions when benefit seems limited.
Finasteride alternatives
Compare other medication classes and procedure pathways.